Ernexa Therapeutics effects 1-for-15 reverse stock split effective June 12, 2025

Ernexa Therapeutics Inc.

Certificate of amendment filed with Delaware Secretary of State on June 10, 2025.
Reverse stock split ratio is 1-for-15.
Effective date of reverse stock split is June 12, 2025.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Ernexa Therapeutics Inc.: Reverse stock split of common stock at 1-for-15 ratio via certificate of amendment to Restated Certificate of Incorporation (effective 2025-06-12).

Change: charter amendment
Effective: 2025-06-12

Exact text from the filing

Effective June 12, 2025, Ernexa Therapeutics Inc. (the “Company”), filed a certificate of amendment to the Company’s Restated Certificate of Incorporation, as amended (the “Amended COI”) with the Secretary of State of Delaware to effect a reverse stock split of the Company’s common stock, at a ratio of 1-for-15.

View on SEC.gov

Browse all governance changes →

Ernexa Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-014877

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.